Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature

Acute respiratory syndrome-related coronavirus 2, or SARS-CoV-2, mainly affects the vulnerable population, especially those with comorbidities, such as pregnant women. SARS-CoV-2 has been found to cause multiple manifestations, one of which is preeclampsia. In preeclampsia, uric acid is excessively...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Melinda-Ildiko Mitranovici, Diana Maria Chiorean, Maria Cezara Mureșan, Corneliu-Florin Buicu, Raluca Moraru, Liviu Moraru, Titiana Cornelia Cotoi, Ovidiu Simion Cotoi, Havva Serap Toru, Adrian Apostol, Sabin Gligore Turdean, Ion Petre, Claudiu Mărginean, Ioan Emilian Oală, Viviana Ivan, Lucian Pușcașiu
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2023-01-01
Seri Bilgileri:	Stresses
Konular:	allopurinol preeclampsia SARS-CoV-2 infection
Online Erişim:	https://www.mdpi.com/2673-7140/3/1/10
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature

Benzer Materyaller